Canada Life
HALO icon

Canada Life’s Halozyme HALO Stock Holding History

Canada Life’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.65M Sell
71,895
-13,397
-16% -$944K 0.01% 774
2025
Q4 		$5.74M Sell
85,292
-7,982
-9% -$537K 0.01% 699
2025
Q3 		$6.83M Sell
93,274
-26,239
-22% -$1.74M 0.01% 689
2025
Q2 		$6.22M Buy
119,513
+13,010
+12% +$740K 0.01% 708
2025
Q1 		$6.8M Sell
106,503
-637
-0.6% -$37K 0.01% 659
2024
Q4 		$5.12M Sell
107,140
-38,605
-26% -$1.98M 0.01% 832
2024
Q3 		$8.35M Buy
145,745
+1,943
+1% +$111K 0.01% 633
2024
Q2 		$7.53M Buy
143,802
+12,946
+10% +$568K 0.01% 642
2024
Q1 		$5.32M Buy
130,856
+29,845
+30% +$1.12M 0.01% 780
2023
Q4 		$3.72M Buy
101,011
+811
+0.8% +$30.5K 0.01% 925
2023
Q3 		$3.83M Buy
100,200
+4,487
+5% +$184K 0.01% 857
2023
Q2 		$3.46M Sell
95,713
-11,933
-11% -$407K 0.01% 896
2023
Q1 		$4.11M Sell
107,646
-2,277
-2% -$107K 0.01% 848
2022
Q4 		$6.26M Buy
109,923
+17,915
+19% +$917K 0.02% 641
2022
Q3 		$3.64M Buy
92,008
+7,544
+9% +$333K 0.01% 815
2022
Q2 		$3.72M Buy
84,464
+8,428
+11% +$365K 0.01% 819
2022
Q1 		$3.11M Buy
76,036
+5,729
+8% +$204K 0.01% 968
2021
Q4 		$2.83M Buy
70,307
+4,379
+7% +$163K 0.01% 1012
2021
Q3 		$2.7M Buy
65,928
+14,217
+27% +$594K 0.01% 1000
2021
Q2 		$2.35M Buy
51,711
+2,427
+5% +$107K 0.01% 1053
2021
Q1 		$2.05M Sell
49,284
-4,138
-8% -$189K 0.01% 1128
2020
Q4 		$2.28M Buy
53,422
+44,685
+511% +$1.61M ﹤0.01% 1069
2020
Q3 		$229K Hold
8,737
– – ﹤0.01% 1867
2020
Q2 		$233K Sell
8,737
-1,752
-17% -$39.5K ﹤0.01% 1877
2020
Q1 		$190K Hold
10,489
– – ﹤0.01% 1825
2019
Q4 		$185K Buy
+10,489
New +$182K ﹤0.01% 1942
2019
Q3 		– Sell
-15,298
Closed -$262K – 1613
2019
Q2 		$262K Sell
15,298
-2,465
-14% -$39.8K ﹤0.01% 1960
2019
Q1 		$285K Buy
17,763
+3,472
+24% +$56.3K ﹤0.01% 1791
2018
Q4 		$202K Hold
14,291
– – ﹤0.01% 1934
2018
Q3 		$260K Hold
14,291
– – ﹤0.01% 1906
2018
Q2 		$241K Hold
14,291
– – ﹤0.01% 1924
2018
Q1 		$281K Hold
14,291
– – ﹤0.01% 1866
2017
Q4 		$289K Hold
14,291
– – ﹤0.01% 1869
2017
Q3 		$248K Buy
14,291
+4,371
+44% +$59.2K ﹤0.01% 1893
2017
Q2 		$127K Hold
9,920
– – ﹤0.01% 2042
2017
Q1 		$128K Hold
9,920
– – ﹤0.01% 2032
2016
Q4 		$98K Hold
9,920
– – ﹤0.01% 2121
2016
Q3 		$120K Hold
9,920
– – ﹤0.01% 2071
2016
Q2 		$85K Hold
9,920
– – ﹤0.01% 2163
2016
Q1 		$94K Hold
9,920
– – ﹤0.01% 1835
2015
Q4 		$171K Hold
9,920
– – ﹤0.01% 1371
2015
Q3 		$133K Hold
9,920
– – ﹤0.01% 1497
2015
Q2 		$223K Hold
9,920
– – ﹤0.01% 1318
2015
Q1 		$141K Buy
9,920
+4,407
+80% +$63.5K ﹤0.01% 1557
2014
Q4 		$53K Hold
5,513
– – ﹤0.01% 2073
2014
Q3 		$50K Hold
5,513
– – ﹤0.01% 2040
2014
Q2 		$54K Hold
5,513
– – ﹤0.01% 1910
2014
Q1 		$70K Hold
5,513
– – ﹤0.01% 1594
2013
Q4 		$83K Buy
+5,513
New +$70.9K ﹤0.01% 1487

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Life's HALO Position: Q1 2026 in Review

Canada Life reduced its Halozyme (HALO) stake by 16% in Q1 2026, selling an estimated $944K and leaving 71,895 shares worth $4.65M. The position accounts for 0.01% of the portfolio, ranked #774.

Canada Life first reported a position in HALO in Q4 2013 and has held it in 49 quarters since. The position peaked at $8.35M in Q3 2024. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Canada Life held 71,895 shares of Halozyme worth $4.65M as of Q1 2026.
  • Canada Life sold 13,397 Halozyme shares in Q1 2026, an estimated $944K.
  • Halozyme made up 0.01% of Canada Life's portfolio in Q1 2026, its #774 holding.
  • Canada Life first reported a position in Halozyme in Q4 2013 and has held it in 49 quarters since.
  • Canada Life's Halozyme position peaked at $8.35M in Q3 2024.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.